Sachetta’s 10x Genomics TXG Stock Holding History

Sachetta’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.7K	Hold	488	–	–	0.01%	312
2026 Q1	$10.4K	Hold	488	–	–	0.01%	434
2025 Q4	$7.96K	Hold	488	–	–	﹤0.01%	449
2025 Q3	$5.71K	Hold	488	–	–	﹤0.01%	574
2025 Q2	$5.65K	Buy	+488	New	+$4.45K	﹤0.01%	556
2024 Q4	–	Sell	-31	Closed	-$700	–	1282
2024 Q3	$700	Sell	31 -60	-66%	-$1.24K	﹤0.01%	1096
2024 Q2	$1.86K	Buy	+91	New	+$2.38K	﹤0.01%	852

Other funds holding TXG

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Sachetta's TXG Position: Q2 2026 in Review

Sachetta held its 10x Genomics (TXG) position steady in Q2 2026 at 488 shares worth $18.7K. The position accounts for 0.01% of the portfolio, ranked #312.

Sachetta first reported a position in TXG in Q2 2024 and has held it in 7 quarters since. 48 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Sachetta held 488 shares of 10x Genomics worth $18.7K as of Q2 2026.
Sachetta left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up 0.01% of Sachetta's portfolio in Q2 2026, its #312 holding.
Sachetta first reported a position in 10x Genomics in Q2 2024 and has held it in 7 quarters since.
48 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.